Molecular epidemiology and characteristic of virulence gene of community-acquired and hospital-acquired methicillin-resistant  isolates in Sun Yat-sen Memorial hospital, Guangzhou, Southern China by unknown
RESEARCH ARTICLE Open Access
Molecular epidemiology and characteristic
of virulence gene of community-acquired
and hospital-acquired methicillin-resistant
Staphylococcus aureus isolates in Sun
Yat-sen Memorial hospital, Guangzhou,
Southern China
Xiaoying Xie1†, Yunwen Bao1†, Nengyong Ouyang2†, Xinlu Dai1, Kunyi Pan1, Baiji Chen1, Yawen Deng1,
Xiquan Wu1, Fengqin Xu1, Hongyu Li1* and Songyin Huang1*
Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of both hospital and community
infections globally. It’s important to illuminate the differences between community-acquired MRSA (CA-MRSA) and
hospital-acquired MRSA (HA-MRSA), but there have been confusions on the definition, especially for the MRSA
isolates identified within 48 h of admission. This study aimed to determine the molecular characteristics and
virulence genes profile of CA and HA-MRSA isolates identified less than 48 h after hospital admission in our region.
Methods: A total 62 MRSA isolates identified within 48 h after admission and the clinical data were collected.
Antimicrobial susceptibility test (AST) of collected isolates were performed according to the guidelines of Clinical
and Laboratory Standards Institute (CLSI) 2015, and staphylococcal cassette chromosome mec (SCCmec) typing,
multilocus sequence typing (MLST), pulsed-field gel electrophoresis (PFGE) and virulence gene profiling were
performed to explore the molecular diversity.
Results: SCCmec III and sequence type (ST) 239 were the most prevalent SCCmec type and ST in both CA and
HA-MRSA groups. HA-MRSA group had higher prevalence of SCCmec III (87.2 %) and ST239 (79.5 %) compared
with CA-MRSA (60.9 and 43.4 %, both P < 0.001), while the frequency of SCCmec IV (26.0 %) and ST59 (21.7 %)
were higher in CA-MRSA than its counterpart (P < 0.001 and P = 0.003). MRSA-ST239-III was the predominant type
in this study (61.3 %, 38/62), especially in HA-MRSA group (76.9 %, 30/39). However, CA-MRSA strains exhibited
more diversity in genotypes in this study. Meanwhile, CA-MRSA tended to have lower resistant percentage to non-
β-lactams antibiotics but more virulence genes carriage, especially the staphylococcal enterotoxins (SE) genes.
Notably, seb gene was only detected in CA-MRSA isolates (52.2 %), likely a significant marker for CA-MRSA isolates.
Panton-Valentine leukocidin gene (PVL) was highly detected in both groups, while appeared no significantly
different between CA-MRSA (47.8 %) and HA-MRSA (43.6 %).
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Conclusions: Our findings support a difference in the molecular epidemiology and virulence genes profile of CA-
MRSA and HA-MRSA. Furthermore, this study indicates a possible transmission from HA-MRSA to CA-MRSA, which
may cause the overlap of the definition.
Keywords: Methicillin-resistant Staphylococcus aureus, Antimicrobial susceptibility, Molecular characteristics,
Virulence gene
Background
Methicillin-resistant Staphylococcus aureus (MRSA) is a
major cause of nosocomial infections around the world
since 1960s, first reported in England [1], and the
increasing prevalence rates were noticed by the re-
searchers in recent years [2, 3]. Otherwise, the
epidemiology of MRSA infection has changed in the past
decades because of the emergence of the strains
acquired outsides the healthcare environment named
community-associated Staphylococcus aureus (CA-
MRSA) [4]. According to the previous reports, CA-
MRSA isolates have somewhat differences from hospital-
acquired MRSA (HA-MRSA) isolates in molecular
characterization, antibiotic resistant pattern, pathogen-
icity and virulence factors [5].
As reported, the predominant HA-MRSA clones in
China are MRSA-ST239-III and MRSA-ST5-II [6]. In
contrast, the main CA-MRSA clones are MRSA-ST59-
VI/V and its single locus varietas MRSA-ST338-IV/V. It
was suggested that most CA-MRSA isolates carry Sta-
phyloccoccal cassette chromosome mec (SCCmec) types
IV and V, do not have multi-antibiotic resistance (except
to β lactams) [7, 8]. However, in some studies recently,
SCCmec IV was identified in HA-MRSA isolates and
SCCmec III was identified in both HA-MRSA and CA-
MRSA isolates, showed that the two SCCmec typing iso-
lates may spread between hospital and community in
some areas [9]. The overlap of molecular characteristic
of CA-MRSA and HA-MRSA was eminently possible in
the MRSA isolates which identified within 48 h after ad-
mission to hospital [10, 11]. As the main metropolises
with a large population of residents and visitors in
Southern China, Guangzhou may have an unique trans-
mission pattern of HA-MRSA and CA-MRSA, especially
the MRSA strains obtained within 48 h of admission,
while rarely studied.
Furthermore, CA-MRSA isolates posses different viru-
lence gene profiles to their counterparts, such as genes,
coding a leukocidin well known for its apoptosis induc-
tion in human polymorphic leukocytes and its lytic ef-
fects in the cells. Since the confusion about definitions
of CA-MRSA and HA-MRSA isolates by traditional
method basic on clinical and epidemiological criterion,
the specific virulence gene (PVL or LukF/lukS-PV) be-
come a new molecular marker [11, 12]. Besides, CA-
MRSA was also shown to have higher expression levels
of hemolysins and superantigens, such as staphylococcal
enterotoxins gene sek and seq, suggesting that they are
more virulent than HA-MRSA [11]. It can be supposed
that these virulence genes may be new candidates of
classified markers, which were few reported as well.
In order to understand the molecular epidemiology
and characterization of virulence gene of CA-MRSA and
HA-MRSA isolates in this region, 39 HA-MRSA and 23
CA-MRSA isolates were collected from Sun Yat-Sen Me-
morial Hospital from Jan.1, 2006 to Dec.31, 2011. These
isolates were genotyped by SCCmec typing and multilo-
cus sequence typing (MLST). The genetic relationship of
the isolates was determined by pulsed-field gel electro-
phoresis (PFGE). The presence of virulence genes in
CA-MRSA and HA-MRSA isolates were determined to
establish their possible relationship to clinical outcomes.
This knowledge will contribute to our understanding of
how the MRSA epidemic has evolved.
Methods
Study design and population
Sun Yat-Sen Memorial Hospital is also known as the
Second Affiliated Hospital of Sun Yat-Sen University.
With more than 4200 staff and 2200 inpatient beds
available, the hospital performs over 50,000 inpatient op-
erations, discharges about 80,000 inpatients, and handles
more than 3 million outpatient visits annually. A
hospital-based retrospect study of 587 inpatients hospi-
talized for < 48 h infected by Staphylococcus aureus, in-
cluded 67 inpatients with MRSA infection in Sun Yat-
Sen Memorial Hospital between Jan.1, 2006 and Dec.31,
2011 were carried out. Five patients with MRSA infec-
tion were eliminated because the strains can’t recovery.
Therefore, a total of 62 compete surveys were obtained,
with an efficiency rate of 92.5 %. Based on the US Cen-
ters for Disease Control and Prevention criteria, we
roughly defined HA-MRSA infections as those patients
who fit any one of the following situations: surgery,
haemodialysis, residence in a long-term care facility or
treatment in hospital during the previous year, presence
of a permanent catheter or percutaneous device at the
time of culture, or previous isolation of MRSA. If the pa-
tients did not meet any of the above risk factors, had an
infection at the time of admission, and the culture of the
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infection was taken within 48 h, then the infection was
considered as CA-MRSA infections. Clinical data related
to the type of infection and outcome (death, improve-
ment, and relapse) of the patients, as well as other data,
were collected for up to a period of 30 days after the
diagnosis of infection by MRSA. All patients, parents or
guardians signed informed consent approving the use of
their specimen samples for research purposes and the
study was approved by the Ethics Committee of Sun
Yat-Sen Memorial Hospital. Ethical committee’s refer-
ence number: [2016]伦备第 (11)号 (Additional file 1).
Bacterial strains
According to the above definition, 39 HA-MRSA isolates
and 23 CA-MRSA isolates were collected from the 62
patients. To avoid sample duplication, isolates that were
consecutively isolated from the same individual were ex-
cluded. All isolates underwent phenotypic identification
using the VITEK® 2 microbial identification system (bio-
Mérieux, Marcy l’Etoile, France) according to the manu-
facturer’s instructions. Antibiotics used for susceptibility
testing included penicillin, erythromycin, clindamycin,
cefuroxime, ceftriaxone, cefoxitin, gentamicin, rifampi-
cin, quinupristin/dalfopristin, trimethoprim/sulfameth-
oxazole, cefotaxime, tetracycline, imipenem, teicoplanin,
vancomycin, ciprofloxacin, and moxifloxacin. Suscepti-
bilities were determined using the disk diffusion method
in accordance with the performance standards for anti-
microbial susceptibility testing, 25rd informational sup-
plement (M100-S25), recommended by the Clinical and
Laboratory Standards Institute. The inducible clindamy-
cin resistance was determined by D-test. All disks were
obtained from Oxoid Ltd (Oxoid, Basingstoke, England),
and S. aureus ATCC 25923 and ATCC29213 were used
as the quality control strain.
Molecular characterization
Bacterial DNA was extracted using DNA extracted kit(-
Tiangen Biotech, Beijing) with lysostaphin according to
the manufacturer’s instructions. The sequence type (ST)
was characterized by MLST, and the products of seven
house-keeping gene fragments were sequenced (Sangon
Biotech, Shanghai) and compared with allele profiles
from database of S. aureus (www.mlst.net/). SCCmec
typing of MRSA strains was conducted by multiplex
PCR method as previously described [13]. The gen-
etic relationship of the isolates was determined by
PFGE as previously described [18]. Cluster analysis
was performed with the software program BioNu-
merics 5.0 (Maths, Belgium) using the Dice coeffi-
cient and the unweighted pair group method
(UPGMA). The isolates with the similarity over 75 %
were clustered in patterns. The presence of the
genes that code for PVL (lukF-PV and lukS-PV),
twelve staphylococcal enterotoxins (sea ~ see, seg ~ sej
and sem-seo), two exfoliative toxins (eta and etb),
four hemolysins (α-hemolysin, β-hemolysin, δ-hemoly-
sin and γ-hemolysin), and the toxic shock syndrome
toxin (tsst-1) and mecA gene was determined using
PCR as previously reported methodologies, with
some modifications [14, 15].
Statistical analysis
In descriptive statistics, frequency and proportions were
calculated for categorical variables. The frequency of
SCCmec type, specimen type and virulence genes were
treated as categorical variables. The chi-square or two-
sided Fisher’s exact test was used to discriminate
whether the distributions of the studied genes or types
were significantly different between HA-MRSA and CA-
MRSA. The only continuous variable, age, was trans-
formed into a categorical variable using the quartiles of
the frequency distribution (~18, 19–60, >60). It was con-
sidered statistically significant if the two-side P-value <
0.05. All statistical analyses were carried out using SPSS
19.0 for Windows (IBM). All susceptibility data and mo-
lecular test results were analyzed using WHONET soft-
ware, version 5.6.
Result
Clinical and epidemiological data
A total of 587 inpatients hospitalized for < 48 h in-
fected by Staphylococcus aureus, included 67 inpa-
tients with MRSA infection between Jan.1, 2006 and
Dec.31, 2011. Five patients with MRSA infection were
eliminated because the strains can’t recovery. There-
fore, a total of 62 compete surveys with 62 MRSA
isolates were obtained. Thirty-nine isolates (62.9 %)
were classified as HA-MRSA and 23 isolates (37.1 %)
were classified as CA-MRSA. HA-MRSA strains were
mainly isolated from patients over 60 years, while
CA-MRSA strains were from the younger ones. The
CA-MRSA strains were generally isolated from skin
lesion secretion and pus (totally 86.9 %, 20/23), caus-
ing infection of skin and soft tissue. HA-MRSA
strains were isolated mainly from sputa (56.4 %, 22/
39), causing pneumonia. Totally 61.3 % of the pa-
tients infected by MRSA had other chronic disease
ever before, like diabetes, hypertension, tumor and
autoimmune disorders. Furthermore, HA-MRSA iso-
lates preferred infecting the patients suffered from
tumor and brain disease as brain trauma and cere-
brovascular disease (totally 35.9 %), while had a better
outcome than the CA-MRSA strains. Spring and au-
tumn were the most popular seasons for CA-MRSA
isolates, while HA-MRSA infection often occurred in
summer and autumn (Details in Table 1).
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Antimicrobial susceptibility
All isolates were susceptible to vancomycin, teicoplanin
and linezolid. HA-MRSA strains had higher resistant
percentage than CA-MRSA to the non-β-lactams
antibiotics, including ciprofloxacin (89.7 % vs. 34.8 %,
P < 0.001), moxifloxacin (39.5 % vs. 17.4 %,P = 0.001),
rifampicin (33.3 % vs. 4.3 %,P < 0.001), and gentamicin
(84.6 % vs. 21.7 %,P < 0.001). High resistance rate to
erythromycin (95.7 and 91.9 %) and clindamycin (95.7
and 92.3 %) were detected from both the CA-MRSA
and HA-MRSA isolates, followed by tetracycline (65.2
and 79.4 % respectively) (Fig. 1 and Additional file 2:
Table S1).
Molecular characteristics of HA-MRSA and CA-MRSA
The distribution of SCCmec types in the 62 MRSA
strains is shown in Fig. 2 and Additional file 2: Table S2.
Among these, SCCmec type III was found in 48 isolates
(77.4 %), followed by type IV (12.9 %) and type I (6.5 %)
of the isolates, respectively. It is interesting to note that
the prevalence of the SCCmec type III was significantly
higher in isolates from HA-MRSA compared with those
from CA-MRSA (87.2 % vs. 60.9 %, P < 0.001), whereas
the SCCmec type IV was more common among isolates
from CA-MRSA (26.0 %. vs. 5.1 %) (P < 0.001). In
addition, SCCmec II and SCCmec V clones were only
found in the HA-MRSA isolates.
Multilocus sequence typing of 62 MRSA strains re-
vealed 12 different sequence types. Among these, ST239
and ST59 the most prevalent, accounting for 66.1 and
11.3 % of all isolates, respectively. The prevalence of the
ST239 was significantly higher in isolates from HA-
MRSA compared with those from CA-MRSA (79.5 % vs.
43.4 %, P < 0.001), whereas the ST59 was more common
among isolates from CA-MRSA (21.7 % vs. 5.1 %, P =
0.003). ST45, ST950, ST338, ST7, ST10 and ST398 were
only found in the CA-MRSA group; ST537, ST5 and
ST8 were found in HA-MRSA group only. Additionally,
a new ST clone ST3073 (3-1-1-8-345-1-1) (ID:5611) was
found in the HA-MRSA group, obtained from nasal se-
cretion of a 26 years female patients in 2009, who suf-
fered from a nasopharyngeal surgical site infection.
Besides, one HA-MRSA was untypable (Additional file
2: Table S3). In short, MRSA-ST239-III were the most
prevalent of all isolates (61.3 %, 38/62), which was
found in 30 (76.9 %) HA-MRSA isolates and eight
(34.8 %) CA-MRSA isolates (Fig. 2 and Additional file
2: Table S4).
Virulence factors
The results of virulence gene analysis are shown in
Table 2. Almost all the isolates contained hla (100 %,
62/62), hlb (90.3 %, 56/62) and hlg (98.4 %, 61/62) genes
but no isolate was hld positive. The sea gene was found
in 37 isolates (59.7 %) and 13 isolates (21.0 %) possessed
the sei gene. The seb and sec gene were found in 12 iso-
lates (19.4 %). The sem was found in seven isolates
(11.3 %). Six isolates (9.7 %) possessed the seo gene and
five isolates (8.1 %) possessed the sen gene. The sed, see
Table 1 Clinical features of the HA-MRSA and CA-MRSA strains
Characteristic CA-MRSA HA-MRSA P-
value(n = 23) (n = 39)
n(%) n(%)
Sex
Male 11(47.8) 24(61.5) 0.427
Female 12(52.2) 15(38.5)
Age
~ 18 5(21.7) 3(7.7) 0.149
19-60 11(47.8) 16(41.0)
> 60 7(30.4) 20(51.3)
Season
Mar. ~May 9(39.1) 1(2.6) 0.001
Jul. ~Aug. 2(8.7) 14(35.9)
Sep. ~Nov. 7(30.4) 15(38.5)
Dec. ~Feb. 5(21.7) 9(23.1)
Clinical source





Infection of skin and soft tissue 20(87.0) 11(28.2) <0.001
Pneumonia 2(8.7) 22(56.4)
Infection of the surgical site 0(0) 6(15.4)
Infection of bone and joint 1(4.3) 0(0)
Underline disease




Brain injury 1(4.3) 10(25.6)
Other 2(8.6) 6(15.4)
Outcomes
Relapse 5(21.7) 9(23.1) 0.809
Improvement 17(73.9) 25(64.1)
Death within 1 month 1(49.4) 3(7.7)
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and sej genes were not found. These 12 genes make up
the enterotoxin gene cluster (egc). The tsst-1 gene was
found in three isolates (4.8 %), exfoliative toxins genes
(eta or etb) were not found. The PVL gene were found
in 11 CA-MRSA isolates (47.8 %) and 17 HA-MRSA iso-
lates (43.6 %) and there were no significant differences
between CA and HA-MRSA strains (Table 2, Additional
file 3: Figure S1).
Among isolates classified as CA-MRSA, the detection
rates of sec and seo were higher than HA-MRSA group
(P < 0.05) and all the seb positive isolates were CA-
MRSA strains (52.2 %, 12/23). On the other hand, seh
gene was only found in HA-MRSA isolates (5.1 %, 2/39).
Furthermore, 65.2 % CA-MRSA strains carried over than
five virulence genes, were obviously higher than that in
HA-MRSA group (35.9 %, P < 0.05).
Table 3 shows the association between clinical diagno-
sis and the presence of virulence genes. The sea, hla,
hlb, and hlg genes were detected in a higher proportion
in patients with MRSA infection. There are no signifi-
cantly different between the different types of infection
groups. The sea and PVL genes were detected in a
higher proportion in patients with pneumonia. But the
sem, sen, seo, tsst-1 genes were not found in MRSA iso-
lates causing pneumonia. Of note, the enterotoxin gene
cluster (sea, seg, sei, sem, sen and seo) was detected in a
higher proportion in patients with surgical site infection





























Fig. 1 Antibiotic resistance rates of 62 MRSA isolates. CA-MRSA vs. HA-MRSA, *P < 0.05
Fig. 2 SCCmec type and ST distribution of the 62 MRSA isolates. CA-MRSA vs. HA-MRSA, *P < 0.05. CA-MRSA, community-acquired methicillin-
resistant Staphylococcus aureus; HA-MRSA, hospital-acquired methicillin-resistant Staphylococcus aureus; SCCmec, staphylococcal cassette chromo-
some mec; ST, sequence types
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genes were significantly associated with skin and soft tis-
sue infection (P < 0.001), and proved to be significant
markers of CA-MRSA isolates.
Genetic relationship by PFGE
Among the 62 S. aureus isolates, PFGE grouped 60 iso-
lates into eight pulsotypes, while two isolates were
untypable. Pattern A was the main PFGE cluster in this
study (55.0 %, 33/60), followed by pattern B (20.0 %, 12/
60). HA-MRSA strains mainly belonged to pattern A
(66.7 %, 26/39) and pattern B (20.5 %, 8/39), while CA-
MRSA didn’t show a predominant pattern as HA-MRSA
strains (Table 4 and Additional file 4: Figure S2).
The combinative analysis of electrophoretic pattern,
SCCmec type, sequence type, virulence factor profile and
drug resistance pattern suggested different resistance
patterns and virulence factor profiles in different PFGE
clusters. Combined with the isolates distribution, it indi-
cated that CA-MRSA exhibited great diversity in genetic
characteristic and tended to be less resistant to non-β-
lactams antibiotics but more virulence genes carried. As
the Table 4 showed, the isolates with pattern C, D, E and
F, mainly CA-MRSA strains, often were resistant to one
or two non-β-lactams antibiotics (TET/E), carried over
than three SE genes besides the three hemolysin genes.
In contrast, 87.9 % of the isolates with pattern A were
MRSA-ST239-III, classified as HA-MRSA, often pre-
sented co-resistance to four or more non-β-lactams anti-
biotics (CIP/CN/E/TET), while only carried one or two
SE genes besides the hemolysin genes (Table 4).
Table 2 Detection of the 20 virulence genes of 62 MRSA






Virulence genes carriage of S. aureus, n (%) P-
valueCA-MRSA HA-MRSA
(n = 62) (n = 23) (n = 39)
sea 37(59.7) 13(56.5) 24(61.5) 0.284
seb 12(19.4) 12(52.2) -
sec 12(19.4) 7(30.4) 5(12.8) 0.039
seg 12(19.4) 3(13.0) 9(23.1) 0.097
seh 2(3.2) - 2(5.1)
sei 13(21.0) 4(17.4) 9(23.1) 0.377
sem 7(11.3) 4(17.4) 3(7.7) 0.086
sen 5(8.1) 3(13.0) 2(5.2) 0.081
seo 6(9.7) 4(17.4) 2(5.1) 0.011
hla 62(100.0) 23(100.0) 39(100.0)
hlb 56(90.3) 20(87.0) 36(92.3) 0.357
hlg 61(98.4) 23(100.0) 38(97.4) 0.545
tsst-1 3(4.8) 2(8.7) 1(2.6) 0.134
PVL 28(45.2) 11(47.8) 17(43.6) 0.670
Sea ~ seo, gene encoding staphylococcal enterotoxins; hla ~ hlg, gene
encodingα-hemolysin ~ γ-hemolysin; tsst-1, gene encoding toxic shock syn-
drome toxin 1; PVL, gene encoding Panton-Valentine leukocidin
Table 3 Detection of the virulence genes of MRSA in accordance with the clinical diagnosis of the associated infection
Virulence
gene
Number and percentage of the MRSA isolates, n(%) P-
valueInfection of the surgical site Infection of skin and soft tissue Pneumonia
(n = 6) (n = 31) (n = 24)
sea 4(66.7) 18(58.1) 15(62.5) 0.422
seb - 11(35.5) 1(4.2) <0.001
sec 1(16.7) 6(19.4) 4(16.7) <0.001
seg 4(66.7) 4(12.3) 3(8.9) <0.001
seh - 1(3.2) 1(4.2) 1.000
sei 3(50.0) 6(19.4) 3(8.9) <0.001
sem 2(33.3) 4(12.3) - <0.001
sen 2(33.3) 2(6.6) - <0.001
seo 2(33.3) 3(9.7) - <0.001
hla 6(100.0) 31(100.0) 23(95.8)
hlb 6(100.0) 27(87.1) 23(95.8) <0.001
hlg 6(100.0) 30(96.8) 23(95.8) 0.235
tsst-1 - 3(9.7) -
PVL 3(50.0) 12(38.7) 12(50.0) 0.210
Sea ~ see, seg ~ sej, sem ~ seo, gene encoding staphylococcal enterotoxins; eta and etb, gene encoding exfoliative toxin A and B; hla ~ hlg, gene encoding α-
hemolysin ~ γ-hemolysin; tsst-1, gene encoding toxic shock syndrome toxin 1; PVL, gene encoding Panton-Valentine leukocidin
The infection of bone and joint group (n = 1) was not included in statistical analysis
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The eight PFGE gene clusters further divided into 22
genotypes. Due to the long time span of and different
tissue resource of isolates, it indicated that there were
not epidemic trend of MRSA strains between 2006 and
2011 in Guangzhou (Additional file 4: Figure S2).
Discussion
MRSA is an increasing problem and its burden con-
tinues to rise in hospital and community setting, leading
to increased morbidity and mortality rates. Despite the
high prevalence, only a few epidemic clones have been
identified in China. As reported, Brazilian or Hungarian
clone (ST239) and the New York/Japan clone (ST5) were
prevalent in some Asia countries, including China [6].
Previous studies from China found the majority HA-
MRSA strains causing bloodstream infection in Shanghai
belonged to above two epidemic clones ST239 and ST5
[16]. Wang et al. reported the first molecular
characterization of CA-MRSA in 2004, belonged to
ST59 [17]. Since then, molecular epidemiology of CA-
MRSA in China had aroused more and more concern.
During the last decade, ST59 (and its single locus variant
ST338) was the major lineage to the CA-MRSA isolates
in China [8, 14]. Consistently in this study, ST239 was
the predominant clone among HA-MRSA strains,
whereas, it is also detected among CA-MRSA. The re-
sult showed that 76.9 % (30/39) ST239 MRSA isolates
belonged to PFGE cluster A suggesting a similar epi-
demiology for both hospital acquired infections and
community acquired infections.
According to the previous reports [18], HA-MRSA is
usually detected with SCCmec type I, II, and III; in con-
trast, CA-MRSA is reported as carrying type IV and V.
In this study, SCCmec III was the dominant type in HA-
MRSA strains (87.3 %), also the main type of CA-MRSA
(60.9 %). This study confirms that CA-MRSA clones par-
tially carry the SCCmec type III and SCCmec type I, as
reported in a recent study in Guangzhou [16]. In previ-
ous studies from the USA [5] and Italy [10], SCCmec
type IV were also found in HA-MRSA. This finding
demonstrates the existence of constant genetic change
in not just CA-MRSA but also in HA-MRSA. These bac-
teria undergo genetic variations that can give rise to iso-
lates with greater capacities for environmental adaption.
Table 4 The relationship of molecular characterization, antimicrobial resistance, and the main virulence factor profiles of 62 MRSA
isolates
PFGE profile SCCmec(n) ST (n) CA-MRSA (n) HA-MRSA (n) The main virulence factor profiles Resistance profile
A(33) I(2) ST8(1) 0 1 sea, PVL, hla,hlb,hlg CIP/CN/E/TET
ST239(1) 0 1
III(30) ST239(29) 7 22
ST1 (1) 0 1
V(1) ST5(1) 0 1
B(12) III (11) ST239(9) 2 7 sea,seg, hla,hlb,hlg CIP/CN/E/TET/RD
ST537(1) 0 1
ST1(1) 1 0
IVa(1) 7(1) 1 0
C (8) I(1) ST59(1) 1 0 sea,seb,seg,PVL, hla,hlb,hlg E/TET
III(1) ST59(1) 1 0
IVa(3) ST59(3) 2 1
IVd(3) ST59(1) 3 0
ST239(1)
ST338(1)
D (2) III(1) ST950(1) 1 0 seg,sei,sem ~ o,PVL, hla,hlb,hlg E
II(1) ST239(1) 0 1
E (2) III(2) ST10(1) 1 0 sea(seb),sec,seg(sei),sem ~ o,PVL,hla,hlb,hlg E
ST3073(1) 0 1
F (1) I(1) ST45(1) 1 0 sec,seg,sei,PVL,hla,hlb,hlg E/TET
G (1) III(1) NT(1) 0 1 hla,hlb,hlg E/TET/RD
H (1) IVa(1) ST59(1) 1 0 seb,PVL, hla,hlb,hlg E/TET
PFGE pulsed-field gel electrophoresis, SCCmec staphylococcal cassette chromosome mec, ST sequence type, Sea ~ see, seg ~ sej, sem ~ seo, gene encoding staphylo-
coccal enterotoxins; eta and etb, gene encoding exfoliative toxin A and B; hla ~ hlg, gene encodingα-hemolysin ~ γ-hemolysin; tsst-1, gene encoding toxic shock
syndrome toxin 1; PVL Panton-Valentine leukocidin, CIP ciprofloxacin, CN gentamicin, E erythromycin, TET tetracycline, RD rifampicin, NT non-typable
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It’s widely assumed that there are two sources of CA-
MRSA: the spread of HA-MRSA from the medical staff
and discharged patients, and the community MSSA
strains acquired the resistance gene mecA. MRSA strains
colonized in the nasal vestibule of hospital staff and pa-
tients can lead the spread in ward [3]. Our recent study
also showed that hospital workers had a high risk of
MRSA nasal carriage, and the carriers may ‘impose’ their
carrier status upon other household members, causing
transmission of HA-MRSA strains to the community
[19]. In this study, the CA-MRSA-ST239-III strains had
a high homology with HA-MRSA, shared the same
PFGE cluster (Patterns A and B), similar virulence factor
profiles and resistance patterns, indicated the strains’
transmission between healthy-care set and community
can lead overlap in the distinction between HA-MRSA
and CA-MRSA.
MRSA strains emerged and diffused in the community
(CA-MRSA) and were shown frequently to carry the
smaller and more easily mobilized SCCmec cassettes and
are generally less drug resistant than their counterparts
acquired in hospitals (HA-MRSA) [11]. Unexpectedly,
except for resistance to all kinds of β-lactam antibiotics,
the MRSA isolates found in our region appeared a high
resistant rate to other non-β-lactam antibiotics, espe-
cially to erythromycin (93.3 %), clindamycin (93.5 %)
and tetracycline (74.2 %), mainly in HA-MRSA strains of
ST239-III in Pattern A. Unlike the HA-MRSA strains,
CA-MRSA strains exhibited great diversity in genetic
characteristic in this study. Except for the MRSA-ST239
and ST59, another seven unique sequence type consti-
tuted almost half of 23 CA-MRSA strains, belonged to
Pattern C ~H respectively. In comparison with HA-
MRSA, these CA-MRSA isolates showed high levels of
sensitivity to ciprofloxacin, moxifloxacin, gentamicin, ri-
fampicin, and trimethoprim/sulfamethoxazole. These re-
sults are consistent with previous studies [20–22].
To our knowledge, this is the first study to provide
insight into the epidemiological and genetic correlation
of the virulence profile present among the different CA-
MRSA and HA-MRSA clones and their clinical diagnosis
in Mainland China. Hemolysin of S. aureus leads the
bacterio-lytic enzyme release to damage the nearby
organizations through effecting the red blood cell,
platelet and neutrophil [23]. α-hemolysin and β-
hemolysin are the main toxin inducing pathological
injury. Consistent with the report in China [23], al-
most all the isolates contained hla, hlb and hlg gene
but no isolate was hld positive. Difference from our
report, the hla, hlb, hlg and hld were all found in
Wenzhou [24]. These findings indicated that the high
hla, hlb and hlg genes but low hld gene present in
the MRSA strains could be a toxin characteristics of
MRSA strains in this region.
In terms of virulence factors, differential content was
reported between CA-MRSA and HA-MRSA isolates.
This study confirms that CA-MRSA strains carried more
virulence genes, especially staphylococcal enterotoxins
genes (seb/sec/sem ~ o). SEs are a major cause of
staphylococcal food poisoning, associated with severe
disease. SEB may suppress the motility of human poly-
morphonuclear neutrophils through the inhibition of
exoprotein expression, and allow MRSA to invade and
damage tissues [25]. Previous studies have confirmed
that the sea and seb genes are the most abundant toxin
genes in clinical S. aureus isolates from patients in China
[26, 27]. Consistently, sea gene was the predominant SE
gene detected in this study. No differences between the
two MRSA groups were detected nor correlation to the
clinical diagnosis. Of note, the seb and sec genes were
significantly associated with skin and soft tissue infection
(P < 0.001), and proved to be significant markers of CA-
MRSA isolates. This study confirms that HA-MRSA
clones predominantly carry the egc cluster(sea, seg, sei,
sem, sen and seo), as reported in Europe and the USA
[28]. Notablely, the tsst-1 gene was only found in the
strains of skin and tissue infection patients, suggesting
that these patients may have a greater potential for de-
veloping fatal toxin shock syndrome (TSS) [16]. Add-
itionally, three SE genes (sed, see and sej) and two ET
genes (eta and etb) were not found in this study.
An important finding in this study was the high detec-
tion rate of the lukF-PV and lukS-PV gene in the 62
MRSA isolates, while appeared no significantly different
between CA-MRSA (47.8 %) and HA-MRSA (43.6 %)
groups. PVL is a pore-forming toxin encoded by lukF-
PV and lukS-PV, belonging to a family of similar bi-
component leukocidin toxins produced by staphylococci,
which is postulated widely as the primary virulence de-
terminant driving the epidemic spread of the major CA-
MRSA clone worldwide [29, 30]. Although PVL is
known as a common virulence factor of CA-MRSA, sev-
eral studies showed the HA-MRSA isolates had a con-
siderable rate of PVL positivity in their regions [31].
Zetola et al. found that the prevalence of PVL tended to
be elevated in nosocomial infections, indicating possible
clonal expansion of those CA-MRSA into the hospital
environment [32].
From the above, PVL may no longer be a reliable
marker for CA-MRSA isolates, rather all MRSA may be
important reservoir of PVL toxin. This indicates that
HA-MRSA with typical molecular characteristics of CA-
MRSA (SCCmec type IVa, V and PVL positive) have
emerged as an important cause of healthcare-associated
infections.
The current work has several limitations. Most im-
portantly, the low number of studied strains and the lack
of bacteremia cases limited the broad representative
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significance of the research. Secondly, the protein ex-
pression of virulence gene was not studied yet. It was re-
ported that the expression of drug-resistance genes in S.
aureus strains could decrease the expression of virulence
factors [25, 33], which need further studied. Thirdly, spa
typing was not performed in the current study, and this
is something that should be conducted in future ana-
lyses. Despite the above limitations, our results add to
the epidemiological information on CA-MRSA and HA-
MRSA, could contribute to more effective disease con-
trol of MRSA infections.
Conclusions
These data indicate a high prevalence of ST239-III-
MRSA in both CA-MRSA and HA-MRSA isolates iden-
tified within 48 h after admission in Sun Yat-Sen Me-
morial Hospital, Guangzhou, but obviously different
characteristic of molecular epidemiology and virulence
genes profile between the CA and HA-MRSA group.
Furthermore, this study indicates a possible transmission
from HA-MRSA to CA-MRSA, that may be useful for
understanding the overlap of the definition of the above
two, and for designing strategies to prevent the MRSA
dissemination.
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